A challenge in the development of dry powder formulations for inhalation is the poor reproducibility of their administration to small laboratory animals. The currently used devices for the pulmonary administration of dry powder formulations to small rodents often function sub-optimally as they use the same puff of air for both powder dispersion and aerosol delivery. As a result, either the air volume and flow rate are too low for complete powder deagglomeration or they are too high for effective aerosol delivery to the lungs of the animal. Therefore, novel and better devices are desired. We here present an aerosol generator designed to administer a pre-generated aerosol to the lungs of mice. By mapping the complex relationship between the a...
Copyright The Author(s) 2013. This article is published with open access at Springerlink.com. This a...
The use of respiratory tract dosimetry predictions to estimate the desired aerosol exposure concentr...
Chapter one reviews the interconnected relationships between dry powder formulation, dry powder inha...
A challenge in the development of dry powder formulations for inhalation is the poor reproducibility...
To evaluate powder formulations for pulmonary administration in pre-clinic research, the powder shou...
Dry powder formulations for inhalation have to be screened in animal studies for therapeutic efficac...
The aim of this study was to evaluate the ability of the Penn-Century Dry Powder Insufflator for mic...
Dry powder inhalers are used by a large number of patients worldwide to treat respiratory diseases. ...
The Penn Century DP-4 Dry Powder Insuflator ™ device has been used extensively to deliver micronised...
Particles suspended in the air are inhaled during normal respiration and unless cleared by airway de...
Objective: Inhalative application of substantial amounts of pulmonary surfactant to the acutely infl...
There is increasing interest in the use of so-called ‘extrafine’ aerosols to target the small airway...
Copyright The Author(s) 2013. This article is published with open access at Springerlink.com. This a...
The use of respiratory tract dosimetry predictions to estimate the desired aerosol exposure concentr...
Chapter one reviews the interconnected relationships between dry powder formulation, dry powder inha...
A challenge in the development of dry powder formulations for inhalation is the poor reproducibility...
To evaluate powder formulations for pulmonary administration in pre-clinic research, the powder shou...
Dry powder formulations for inhalation have to be screened in animal studies for therapeutic efficac...
The aim of this study was to evaluate the ability of the Penn-Century Dry Powder Insufflator for mic...
Dry powder inhalers are used by a large number of patients worldwide to treat respiratory diseases. ...
The Penn Century DP-4 Dry Powder Insuflator ™ device has been used extensively to deliver micronised...
Particles suspended in the air are inhaled during normal respiration and unless cleared by airway de...
Objective: Inhalative application of substantial amounts of pulmonary surfactant to the acutely infl...
There is increasing interest in the use of so-called ‘extrafine’ aerosols to target the small airway...
Copyright The Author(s) 2013. This article is published with open access at Springerlink.com. This a...
The use of respiratory tract dosimetry predictions to estimate the desired aerosol exposure concentr...
Chapter one reviews the interconnected relationships between dry powder formulation, dry powder inha...